NCT06593834View on ClinicalTrials.gov

A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

NANot yet recruitingINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Acute Graft-versus-host Disease

Interventions

DRUG

bacillus coagulans combined with the best treatment options for preventing aGVHD

BAT means the best treatment options for preventing aGVHD

DRUG

BAT

All Listed Sponsors

lead

Yamin Fan

OTHER

NCT06593834 - A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter